Kisqali (200 MG Dose) and Novoeight
Determining the interaction of Kisqali (200 MG Dose) and Novoeight and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali (200 MG Dose)-Novoeight recombinant
- Kisqali (200 MG Dose)-Novolin 70/30
- Kisqali (200 MG Dose)-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Kisqali (200 MG Dose)-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Kisqali (200 MG Dose)-Novolin N
- Kisqali (200 MG Dose)-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Novoeight-Kisqali (400 MG Dose)
- Novoeight-Kisqali (600 MG Dose)
- Novoeight-Kisqali Femara Co-Pack
- Novoeight-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Novoeight-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Novoeight-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose